Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.

Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.

Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects.To report the 12-month extension of a phase II trial evaluating the efficacy, safety and tolerability of atorvastatin 40 mg/d added to interferon beta-1b (IFNB-1b) in relapsing-remitting multiple scl...

Full description

Bibliographic Details
Main Authors: Christian P Kamm, Marwan El-Koussy, Sebastian Humpert, Oliver Findling, Yuliya Burren, Guido Schwegler, Filippo Donati, Martin Müller, Felix Müller, Johannes Slotboom, Ludwig Kappos, Yvonne Naegelin, Heinrich P Mattle, SWABIMS Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3907426?pdf=render

Internet

http://europepmc.org/articles/PMC3907426?pdf=render

Similar Items